1. Home
  2. RFL vs OPXS Comparison

RFL vs OPXS Comparison

Compare RFL & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • OPXS
  • Stock Information
  • Founded
  • RFL 2017
  • OPXS 1987
  • Country
  • RFL United States
  • OPXS United States
  • Employees
  • RFL N/A
  • OPXS N/A
  • Industry
  • RFL Real Estate
  • OPXS Electronic Components
  • Sector
  • RFL Finance
  • OPXS Technology
  • Exchange
  • RFL Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • RFL 48.4M
  • OPXS 54.2M
  • IPO Year
  • RFL N/A
  • OPXS N/A
  • Fundamental
  • Price
  • RFL $2.40
  • OPXS $8.42
  • Analyst Decision
  • RFL
  • OPXS
  • Analyst Count
  • RFL 0
  • OPXS 0
  • Target Price
  • RFL N/A
  • OPXS N/A
  • AVG Volume (30 Days)
  • RFL 54.6K
  • OPXS 18.9K
  • Earning Date
  • RFL 10-28-2024
  • OPXS 11-12-2024
  • Dividend Yield
  • RFL N/A
  • OPXS N/A
  • EPS Growth
  • RFL N/A
  • OPXS 132.50
  • EPS
  • RFL N/A
  • OPXS 0.61
  • Revenue
  • RFL $540,000.00
  • OPXS $32,628,999.00
  • Revenue This Year
  • RFL N/A
  • OPXS N/A
  • Revenue Next Year
  • RFL N/A
  • OPXS N/A
  • P/E Ratio
  • RFL N/A
  • OPXS $13.88
  • Revenue Growth
  • RFL 92.86
  • OPXS 34.17
  • 52 Week Low
  • RFL $1.29
  • OPXS $3.75
  • 52 Week High
  • RFL $2.44
  • OPXS $8.99
  • Technical
  • Relative Strength Index (RSI)
  • RFL 87.25
  • OPXS 63.68
  • Support Level
  • RFL $2.00
  • OPXS $7.78
  • Resistance Level
  • RFL $1.94
  • OPXS $8.46
  • Average True Range (ATR)
  • RFL 0.10
  • OPXS 0.28
  • MACD
  • RFL 0.03
  • OPXS 0.08
  • Stochastic Oscillator
  • RFL 94.85
  • OPXS 95.41

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Richardson and Applied Optics Center Dallas. It generates maximum revenue from the Applied Optics Center Dallas segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: